• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 12 Feb 2025

BQE: Evaluating the Blue-Sky Opportunity


BQE Water Inc (BQE:TSX) | 0 0 0.0%


  • Atrium Research
    • Nicholas Cortellucci, CFA

    • 5 pages


 

What you need to know: • BQE has various blue-sky opportunities ahead which we do not account for in our model. This report breaks down each opportunity to paint a picture of a bull case scenario for the Company. • This includes company maker projects, new applications and technologies, the mining bull cycle, capital allocation plans, geographic expansion, trust in management, and multiple expansion. Since BQE Water (BQE:TSXV, BTQNF:OTC) stock has stabilized over the past few months, we would like to spend some time outlining the blue sky opportunity ahead for the Company. This includes various factors that are not accounted for in our model including company maker projects, new applications of its IP, the mining bull cycle, capital allocation, geographic expansion, trust in management, and multiple expansion. In this blue-sky scenario, we can see BQE posting $15M in EBITDA in 2027 and trading at 13x EBITDA, resulting in a blue-sky target of $156/share. We are maintaining our BUY rating and $80.00/share target price on BQE Water. Company Maker Projects BQE has three “company maker” projects in its existing pipeline. Over the years, these projects have gradually progressed through early stages of development which involved BQE’s services to complete technical assessments, piloting, and/or permitting, and have a realistic chance of proceeding to the implementation phase in the time horizon of the next 2 to 5 years. Management defines the company maker projects as water treatment plants with capex >$100M integrated into world-class mining assets with an operating life of over 30 years. Each one of the projects is estimated to generate >$6M in annual recurring revenue for BQE. Reviewing the Company’s newsletters and MD&As over the last three years, we believe that one of the projects is likely Seabridge Gold’s KSM project in BC. KSM received environmental approvals specifically using BQE’s water treatment technology (including selenium); meaning that if the KSM Mine moves towards production, it will be using BQE. This is largely dependent on Seabridge receiving the necessary financing to move KSM into production ($6.4B) which we see a strong likelihood of happening given its development stage and the rising gold price. Mining.com reported in August that KSM is in partnership conversations with six major gold and copper companies after receiving its “Substantially Started” designation from the B.C. government. However, the project has recently struggled, having been challenged by a First Nations group and Earthjustice. We remind readers that KSM has a P&P resource of 47.3Moz of gold and 7.3 Blbs of copper and is expected to have a 52-year mine life. As per its 2022 pre-feasibility study, the selenium water treatment will cost Seabridge US$19.6M per year for the life of mine. KSM is likely to have multiple plants through its construction and operational stages. While we do not include any company maker projects in our model, this provides a blue-sky scenario that would transform BQE’s revenue profile.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

BQE: Evaluating the Blue-Sky Opportunity


BQE Water Inc (BQE:TSX) | 0 0 0.0%


  • Published: 12 Feb 2025
  • Author: Nicholas Cortellucci, CFA
  • Pages: 5
  • Atrium Research


What you need to know: • BQE has various blue-sky opportunities ahead which we do not account for in our model. This report breaks down each opportunity to paint a picture of a bull case scenario for the Company. • This includes company maker projects, new applications and technologies, the mining bull cycle, capital allocation plans, geographic expansion, trust in management, and multiple expansion. Since BQE Water (BQE:TSXV, BTQNF:OTC) stock has stabilized over the past few months, we would like to spend some time outlining the blue sky opportunity ahead for the Company. This includes various factors that are not accounted for in our model including company maker projects, new applications of its IP, the mining bull cycle, capital allocation, geographic expansion, trust in management, and multiple expansion. In this blue-sky scenario, we can see BQE posting $15M in EBITDA in 2027 and trading at 13x EBITDA, resulting in a blue-sky target of $156/share. We are maintaining our BUY rating and $80.00/share target price on BQE Water. Company Maker Projects BQE has three “company maker” projects in its existing pipeline. Over the years, these projects have gradually progressed through early stages of development which involved BQE’s services to complete technical assessments, piloting, and/or permitting, and have a realistic chance of proceeding to the implementation phase in the time horizon of the next 2 to 5 years. Management defines the company maker projects as water treatment plants with capex >$100M integrated into world-class mining assets with an operating life of over 30 years. Each one of the projects is estimated to generate >$6M in annual recurring revenue for BQE. Reviewing the Company’s newsletters and MD&As over the last three years, we believe that one of the projects is likely Seabridge Gold’s KSM project in BC. KSM received environmental approvals specifically using BQE’s water treatment technology (including selenium); meaning that if the KSM Mine moves towards production, it will be using BQE. This is largely dependent on Seabridge receiving the necessary financing to move KSM into production ($6.4B) which we see a strong likelihood of happening given its development stage and the rising gold price. Mining.com reported in August that KSM is in partnership conversations with six major gold and copper companies after receiving its “Substantially Started” designation from the B.C. government. However, the project has recently struggled, having been challenged by a First Nations group and Earthjustice. We remind readers that KSM has a P&P resource of 47.3Moz of gold and 7.3 Blbs of copper and is expected to have a 52-year mine life. As per its 2022 pre-feasibility study, the selenium water treatment will cost Seabridge US$19.6M per year for the life of mine. KSM is likely to have multiple plants through its construction and operational stages. While we do not include any company maker projects in our model, this provides a blue-sky scenario that would transform BQE’s revenue profile.

More Content

More Content

BQE: Monster Q1 Beat on Technical Services Outperformance

Companies: BQE Water Inc

Atrium Research

BQE: Profitable & Growing Micro-Cap in the Water Treatment Industry

Companies: BQE Water Inc

Atrium Research

BQE: Wrapping Up Another Record Year

Companies: BQE Water Inc

Atrium Research

BQE: Q4 Financials Preview

Companies: BQE Water Inc

Atrium Research

Q1/25 Recap: All Our Research in One Place!

Companies: NIM SCZ DRX AUAU ARG OMG BQE DNG EDG KNR MOO NIM RIO SBIO LVG TOC TM SCZ CAPT GIGA APM FISH

Atrium Research
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Acquisdata
      • Actinver
      • Actio Advisors
      • Asset TV
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Brand Communications
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD (hosted by Progressive)
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In